TCM
LMNL

Tanaka Capital Management’s Liminal BioSciences Inc. Common Shares LMNL Stock Holding History

Tanaka Capital Management’s Portfolio LMNL Stock Details LMNL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1
Closed – – 49
2023
Q3 		$0 Hold
1
– – ﹤0.01% 46
2023
Q2 		$0 Hold
1
– – ﹤0.01% 47
2023
Q1 		$0 Sell
1
-1
-50% -$5 ﹤0.01% 48
2022
Q4 		$0 Hold
2
– – ﹤0.01% 47
2022
Q3 		$0 Hold
2
– – ﹤0.01% 48
2022
Q2 		$0 Hold
2
– – ﹤0.01% 51
2022
Q1 		$0 Hold
2
– – ﹤0.01% 51
2021
Q4 		$0 Hold
2
– – ﹤0.01% 54
2021
Q3 		$0 Hold
2
– – ﹤0.01% 54
2021
Q2 		$0 Hold
2
– – ﹤0.01% 54
2021
Q1 		$0 Hold
2
– – ﹤0.01% 48
2020
Q4 		$0 Hold
2
– – ﹤0.01% 49
2020
Q3 		$0 Hold
2
– – ﹤0.01% 51
2020
Q2 		$0 Hold
2
– – ﹤0.01% 50
2020
Q1 		$0 Hold
2
– – ﹤0.01% 48
2019
Q4 		$0 Buy
+2
New +$135 ﹤0.01% 49

Tanaka Capital Management's LMNL Position: Q4 2023 in Review

Tanaka Capital Management sold out of Liminal BioSciences Inc. Common Shares (LMNL) in Q4 2023, closing a stake of 1 share.

Tanaka Capital Management first reported a position in LMNL in Q4 2019 and held it in 16 quarters. The position peaked at $0 in Q3 2023. 0 funds tracked by Wall St. Rank hold LMNL as of Q4 2023.

  • Tanaka Capital Management reported no remaining Liminal BioSciences Inc. Common Shares position as of Q4 2023 after selling out during the quarter.
  • Tanaka Capital Management sold 1 Liminal BioSciences Inc. Common Shares share in Q4 2023.
  • Tanaka Capital Management first reported a position in Liminal BioSciences Inc. Common Shares in Q4 2019 and held it in 16 quarters.
  • Tanaka Capital Management's Liminal BioSciences Inc. Common Shares position peaked at $0 in Q3 2023.
  • 0 funds tracked by Wall St. Rank held Liminal BioSciences Inc. Common Shares as of Q4 2023.

Based on Tanaka Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.